SolasCure publishes phase IIa clinical trial report in leading wound care journal

FHS
March 4, 2024
9:35 am

Study demonstrates proof-of-concept and strong safety profile of Aurase Wound Gel in patients suffering from chronic wounds.

RM-191A by RR MedSciences for Neuropathic Pain (Neuralgia): Likelihood of Approval

RM-191A is under clinical development by RR MedSciences and currently in Phase II for Neuropathic Pain (Neuralgia).

February 20, 2024

Cue Health axes more jobs amid declining test sales

Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Cue Health announced two rounds

February 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.

SolasCure publishes phase IIa clinical trial report in leading wound care journal

BU study reveals key to combating high-risk neuroblastoma

RM-191A by RR MedSciences for Neuropathic Pain (Neuralgia): Likelihood of Approval

Cue Health axes more jobs amid declining test sales

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

Subscribe